Livzon Pharmaceutical Gro... (LVZPF)
PNK: LVZPF
· Real-Time Price · USD
3.43
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 2.8 |
| Market Cap | 4.01B |
| Revenue (ttm) | 11.71B |
| Net Income (ttm) | 2.09B |
| EPS (ttm) | 0.3 |
| PE Ratio (ttm) | 11.43 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.8 |
| Volume | 108 |
| Avg. Volume (20D) | 81.395 |
| Open | 3.20 |
| Previous Close | 3.43 |
| Day's Range | 3.20 - 3.43 |
| 52-Week Range | 3.20 - 3.63 |
| Beta | 0.41 |
About LVZPF
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitrop...
Sector Healthcare
IPO Date Jun 29, 2018
Employees 9,067
Stock Exchange PNK
Ticker Symbol LVZPF
Website https://www.livzon.com.cn